Sign in
Deutsch
Русский
MarketCap
Company ratings
Stock Market
Stock Screener
Companies Financial Statements
Fundamental Company Screener
Company ratings
Fundamental Company Screener
Companies Financial Statements
Stock Screener
Cryptocurrency
Home
Companies
Inhibikase Therapeutics
Chart
Inhibikase Therapeutics
IKT
$ 2.43
0.4%
Stock price in USD
Stock price in EUR
Facebook
X
Telegram
Quarterly report
2026-Q2
added 08-11-2026
Profile
Stock Chart
Financial Statements
Financial Ratios
Inhibikase Therapeutics Chart for All Time | IKT
MarketCap
Facebook
X
Telegram